1. Home
  2. EVO vs GBX Comparison

EVO vs GBX Comparison

Compare EVO & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • GBX
  • Stock Information
  • Founded
  • EVO 1993
  • GBX 1974
  • Country
  • EVO Germany
  • GBX United States
  • Employees
  • EVO N/A
  • GBX N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • GBX Railroads
  • Sector
  • EVO Health Care
  • GBX Industrials
  • Exchange
  • EVO Nasdaq
  • GBX Nasdaq
  • Market Cap
  • EVO 1.4B
  • GBX 1.5B
  • IPO Year
  • EVO 2021
  • GBX N/A
  • Fundamental
  • Price
  • EVO $3.31
  • GBX $42.63
  • Analyst Decision
  • EVO Strong Buy
  • GBX Hold
  • Analyst Count
  • EVO 1
  • GBX 2
  • Target Price
  • EVO $7.00
  • GBX $57.00
  • AVG Volume (30 Days)
  • EVO 54.5K
  • GBX 371.1K
  • Earning Date
  • EVO 11-05-2025
  • GBX 10-28-2025
  • Dividend Yield
  • EVO N/A
  • GBX 3.00%
  • EPS Growth
  • EVO N/A
  • GBX 27.96
  • EPS
  • EVO N/A
  • GBX 6.35
  • Revenue
  • EVO $887,396,457.00
  • GBX $3,240,200,000.00
  • Revenue This Year
  • EVO N/A
  • GBX N/A
  • Revenue Next Year
  • EVO $10.78
  • GBX N/A
  • P/E Ratio
  • EVO N/A
  • GBX $6.72
  • Revenue Growth
  • EVO N/A
  • GBX N/A
  • 52 Week Low
  • EVO $2.84
  • GBX $37.77
  • 52 Week High
  • EVO $5.64
  • GBX $71.06
  • Technical
  • Relative Strength Index (RSI)
  • EVO 28.61
  • GBX 38.87
  • Support Level
  • EVO $3.30
  • GBX $40.93
  • Resistance Level
  • EVO $4.09
  • GBX $46.33
  • Average True Range (ATR)
  • EVO 0.09
  • GBX 1.28
  • MACD
  • EVO -0.08
  • GBX -0.24
  • Stochastic Oscillator
  • EVO 2.06
  • GBX 53.44

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: